Home/Tag: drug

Drug

Rise in abuse of stimulant medication by teens

By |2016-10-05T06:46:12-04:00August 25th, 2009|Categories: ADHD, Books, Depression/Anxiety, Events, Research|Tags: , , , , |

A WebMD article states: Researchers found calls to poison control centers for adolescent ADHD prescription drug abuse increased out of proportion to other poison center calls in recent years, which suggests a growing problem with abuse of these stimulant drugs. The article also goes on to state that the study found that there was an increase [...]

Comments Off on Rise in abuse of stimulant medication by teens

Article on Secretin clinical trial for Autism

By |2016-10-05T06:46:13-04:00June 27th, 2008|Categories: Autism, Medication, Research|Tags: , , , , , , , , , |

In 2003, we were a site that participated in conducting a clinical trial for Secretin. The purpose of the study was to determine safety and efficacy of Secretin versus placebo in the treatment of Autism symptoms.  Unfortunately, the study results found that there was no difference in symptom change between children on Secretin and those on placebo.   Here's an article on [...]

Comments Off on Article on Secretin clinical trial for Autism

Scientists find novelty-seeking area of brain

By |2016-10-05T06:46:13-04:00June 26th, 2008|Categories: ADHD, Research|Tags: , , , , , , |

When you have to have the newest tech gadget or go skydiving for the first time, your ventral striatum may be the culprit.  The ventral striatum is also the section of the brain where drug and alcohol use induces the release of dopamine.  In addition, compared to people without ADHD, people with ADHD have reduced activation in the ventral [...]

Comments Off on Scientists find novelty-seeking area of brain

Results from Phase II study with new ADHD drug

By |2016-10-05T06:46:13-04:00June 20th, 2008|Categories: ADHD, Medication, Research|Tags: , , , , , , , , , |

ABT-894 is a drug that is currently undergoing clinical trials for possible approval by the FDA for the treatment of adult ADHD.  Drugs have to undergo specific study phases and must demonstrate safety and efficacy before they are approved by the FDA.  ABT-894 is a neuronal nictotinic receptor (NNR) modulator.  NNRs modulate the release of neurotransmitters such as acetylcholine and [...]

Comments Off on Results from Phase II study with new ADHD drug